Sleep Apnea Diagnostic System Market, By Product Type (Polysomnography (PSG) Devices (Ambulatory PSG Monitoring Devices, Clinical PSG Monitoring Devices), Sleep Apnea Screening Devices (Nasal Flow Sensors, Peripheral Capillary Oxygen Saturation (SPO2), Actigraphy Monitoring Devices)), By End User (Home Care Settings, Hospitals, Sleep Centers and Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023

Code : CMI3435

Pages :175

Formats :

Excel and PDF

Industry : Medical Devices

Sleep Apnea Diagnostic System MarketSize and Trends

The global sleep apnea diagnostic system market is estimated to be valued at US$ 10.7 billion in 2023 and is expected to exhibit a CAGR of 8.1% during the forecast period (2023-2030).

Figure 1. Global Sleep Apnea Diagnostic System Market Share (%), by Product Type, 2023

Based on Product Type, the market is segmented into Polysomnography (PSG) Devices, (Ambulatory PSG Monitoring Devices, Clinical PSG Monitoring Devices), Sleep Apnea Screening Devices,(Nasal Flow Sensors, Peripheral Capillary Oxygen Saturation (SPO2)), and Actigraphy Monitoring Devices. Out of which, the Polysomnography (PSG) Devices segment is expected to hold a dominant position in the global sleep apnea diagnostic system market during the forecast period and this is attributed to the increase in technological advancement.

Based on End User, the market is segmented into Homecare Settings, Hospitals, Sleep Centers, and Clinics. Out of which, the Sleep Centers and Clinics segment is expected to dominate the market over the forecast period and this is attributed to the increase in the prevalence of obstructive sleep apnea which is leading towards the increase in a number of patient admissions in sleep centers and clinics.

Among all segmentation, the product type segment has the highest potential due to the increasing technological advancement in sleep apnea diagnostic systems over the forecast period. For instance, in September 2022, Onera Technologies B.V., a leader in transforming sleep medicine and remote monitoring, announced the official launch of its ground-breaking solution to diagnose sleep disorders in Europe. The service is based on the company’s Conformite Europeenne (CE)-marked and FDA-cleared Onera Sleep Test System and the Onera Digital Health Platform. It allows sleep professionals to conduct sleep studies in the comfort of the patient’s home while maintaining clinical-grade quality as with in-lab diagnostics.

Global Sleep Apnea Diagnostic System Market Cross Sectional Analysis:

Obstructive sleep apnea (OSA) is strongly associated with cardiovascular disease (CVD), is leading towards an increasing number of patient admissions in the sleep centers and clinics which is expected to drive the growth of the global sleep apnea diagnostic system market over the forecast period. For instance, according to the article published in National Center for Biotechnology Information, in June 2022, it is stated that a few studies in Asia have reported an OSA prevalence ranging from 4.1% to 7.5% in men and from 2.1% to 4.5% in women, with an overall prevalence of 8.5% in the general adult population aged >18 years.